CIK 0001662579 · Non-accelerated filer<br>Smaller reporting company
C4 Therapeutics, Inc.
Sign in to watch- Ticker
- CCCC
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 475617627
- Phone
- (617) 231-0700
- Business address
- 490 ARSENAL WAY, SUITE 120, WATERTOWN, MA, 02472
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-02-14 | Crystal Adam Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +118,000 | 118,000 | ||
| 2022-02-14 | Crystal Adam Chief Medical Officer | Grant or award · Performance Restricted Stock Units | +26,250 | 26,250 | ||
| 2022-01-26 | Anderson Kenneth Carl Director | Option exercise | +803 | $2.11 | $2K | 86,641 |
| 2022-01-26 | Anderson Kenneth Carl Director | Option exercise | +1,334 | $4.98 | $7K | 87,975 |
| 2022-01-26 | Anderson Kenneth Carl Director | Option exercise · Stock Option (Right to Buy) | −803 | 2,137 | ||
| 2022-01-26 | Anderson Kenneth Carl Director | Option exercise · Stock Option (Right to Buy) | −1,334 | 2,668 | ||
| 2022-01-04 | Salter Malcolm Director | Grant or award | +428 | $31.58 | $14K | 11,380 |
| 2022-01-04 | COHEN MARC A Director | Grant or award | +657 | $31.58 | $21K | 1,118 |
| 2022-01-04 | Dubin Glenn Director | Grant or award | +199 | $31.58 | $6K | 494 |
| 2022-01-04 | COHEN ALAIN J Director | Grant or award | +318 | $31.58 | $10K | 540 |
| 2022-01-04 | Anderson Kenneth Carl Director | Grant or award | +278 | $31.58 | $9K | 85,838 |
| 2022-01-04 | Crystal Adam Chief Medical Officer | Option exercise | +15,000 | $6.49 | $97K | 30,000 |
| 2022-01-04 | Crystal Adam Chief Medical Officer | Sale | −13,946 | $31.59 | $441K | 16,054 |
| 2022-01-04 | Crystal Adam Chief Medical Officer | Sale | −1,054 | $32.66 | $34K | 15,000 |
| 2022-01-04 | Crystal Adam Chief Medical Officer | Option exercise · Stock Option (Right to Buy) | −15,000 | 112,292 | ||
| 2021-12-22 | Crystal Adam Chief Medical Officer | Option exercise | +5,000 | $6.49 | $32K | 15,000 |
| 2021-12-22 | Crystal Adam Chief Medical Officer | Option exercise · Stock Option (Right to Buy) | −5,000 | 127,292 | ||
| 2021-12-17 | Salter Malcolm Director | Sale | −755 | $30.25 | $23K | 10,952 |
| 2021-12-08 | Fisher Stewart Chief Scientific Officer | Option exercise | +2,373 | $2.11 | $5K | 25,117 |
| 2021-12-08 | Fisher Stewart Chief Scientific Officer | Option exercise | +17,786 | $3.71 | $66K | 42,903 |
Page 18 of 27 · 525 trades